Kidney Graft Function Under the Immunosuppression Strategies
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
To demonstrate that cyclosporine-sparing immunosuppressions with the standard dose of
Enteric-Coated Mycophenolate Sodium would preserve renal graft function after transplantation
without an increase of incidences of adverse events, such as biopsy confirmed acute
rejection, local or systemic infections, and bone marrow suppression.